Short of the money, yes, and if the current operating strategy continues, will never get anywhere near it.
As to the time frame - hardly. 7 years in and they haven't passed Phase 1 - you wouldn't need very high expectations to consider that below average.
Ann: R327 added to WHO List of Antibacterial Products, page-17
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.5¢ | 46.0¢ | $19.60K | 42.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 41004 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 38272 | 2 |
View Market Depth
| Last trade - 15.56pm 26/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |